Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05594394 · ClinicalTrials.gov registry record
Improving Charge Nurse Conflict Resolution Communication Using Artificial Intelligence
A clinical trial, sponsored by Methodist Health System.
- Completed
- Registry status
- 35
- Enrollment target
NCT05594394: Completed study, sponsored by Methodist Health System.
NCT05594394 is a clinical trial that has completed, run by Methodist Health System. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05594394 has completed, sponsored by Methodist Health System.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
Nurses are being challenged to provide increasingly complex care with more inexperienced nurses due to higher rates of retirement and registered nurse (RN) turnover in general. High-performing charge nurses with excellent interpersonal, conflict management, communication, and leadership competencies are vital to achieving optimal outcomes. Implementing a charge nurse leadership development program focused on improving communication competencies in conflict management situations can support a healthy work environment.
Primary Outcome
The CMCSS is a validated tool, r= α=0.86, measuring nurses' confidence in managing challenging situations
Interventions
- BEHAVIORAL Orai: Master Public Speaking
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2022-09-19 |
| Est. Completion | 2023-08-29 |
What the finished NCT05594394 record still lists
NCT05594394 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Orai: Master Public Speaking is the first listed.
NCT05594394 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05594394 about?
NCT05594394 is a clinical study titled "Improving Charge Nurse Conflict Resolution Communication Using Artificial Intelligence". Nurses are being challenged to provide increasingly complex care with more inexperienced nurses due to higher rates of retirement and registered nurse (RN) turnover in general. High-performing charge nurses with excellent interpersonal, conflict management, communication, and leadership competencie...
What is the current status of trial NCT05594394?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2022-09-19. Estimated completion is 2023-08-29.
What interventions are being tested in trial NCT05594394?
The interventions under investigation include: Orai: Master Public Speaking (BEHAVIORAL).
Who is sponsoring clinical trial NCT05594394?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI